HTT and Huntington disease: Previously, we have shown in a proof-of-concept using antisense oligonucleotides to induce skipping of exon 12 in huntingtin (HTT) pre-mRNA, thereby preventing the formation of a 586 amino acid N-terminal huntingtin fragment implicated in HD toxicity [16].